The digital ophthalmology company Eyenovia has invested $50 million to establish the HYPE reserve
ChainCatcher news, the NASDAQ-listed company Eyenovia, focused on the development of digital ophthalmic medical technology, announced the completion of a $50 million PIPE financing, which will be used to purchase the Hyperliquid native token HYPE, and plans to become one of its global major validation nodes.The total fundraising cap for this transaction is expected to be $150 million, and the company will also be renamed "Hyperion DeFi," with the stock code changing to "HYPD." The new Chief Investment Officer Hyunsu Jung will be responsible for executing the cryptocurrency treasury strategy. Eyenovia will also continue to advance its ophthalmic device FDA registration plan, aiming for completion by September 2025.